Indications |
Vaginal Vulvovaginal candidiasis Adult: 40 mg (as 0.8% vag cream) or 80 mg (as pessary) at bedtime for 3 consecutive nights or 20 mg (as 0.4% cream) at bedtime for 7 consecutive nights. |
Contraindications |
Hypersensitivity. Lactation. |
Warnings / Precautions |
Discontinue if irritation or flu-like symptoms develop. May damage latex or rubber contraceptives. Patients <18 yrs. Pregnancy. |
Adverse Reactions |
Vulvovaginal burning, vulvar itching, dysmenorrhoea, genital, body and abdominal pain. Flu-like syndrome with headache, fever, chills and hypotension with doses >80 mg. |
Mechanism of Actions |
Terconazole disrupts ergosterol synthesis by binding to fungal cytochrome P450. It is active in vitro against Candida spp and other fungi. It has some antibacterial activity in vitro but not against usual vag flora eg, lactobacilli. Absorption: Intravaginal: 5-16% absorbed Metabolism: Hepatic metabolism Excretion: Excreted in urine and faeces. |
Storage Conditions |
Vaginal: Store between 15-30°C. |
ATC Classification |
G01AG02 - terconazole ; Belongs to the class of triazole derivative antiinfectives. Used in the treatment of gynecological infections. |
Storage |
Vaginal: Store between 15-30°C. |
Available As |
|
Terconazole
Post Review about Terconazole Click here to cancel reply.
Terconazole Containing Brands
Terconazole is used in following diseases
Drug - Drug Interactions of Terconazole
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.